Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8<sup>+</sup> T cell immunity against bulky tumors via an IFN-I/NK/DC axis.

Nature communications·2026
Same author

High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy.

International journal of cancer·2026
Same author

Naïve pooling of randomized and non-randomized evidence in network meta-analyses: a meta-epidemiological study protocol.

Frontiers in medicine·2026
Same author

Clinical and Inflammatory Phenotypes During Exacerbations Predict In-Hospital Adverse Outcomes in Asthma-COPD Overlap.

Respirology (Carlton, Vic.)·2026
Same author

Physical fitness and bone health among medical students in Southwest China: implications for health promotion in ethnically diverse populations.

Journal of health, population, and nutrition·2026
Same author

Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials.

International journal of cancer·2026

相关实验视频

Updated: Sep 20, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201

基于前性研究的早期NSCLC没有淋巴结参与的比较有效性.

Xue Yang1, Zherui Xing1, Sirui Long1

  • 1Division of Thoracic Tumor Multimodality Treatment, Cancer Center & State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

International journal of surgery (London, England)
|May 28, 2025
PubMed
概括
此摘要是机器生成的。

系统疗法,如手术加辅助向治疗 (ATKI) 或与免疫疗法相结合的立体体辐射疗法 (SBRT),为早期非小细胞肺癌 (eNSCLC-N0) 提供更好的治疗结果. 这些先进的治疗方法可以根据基因组状况和患者的耐受性提高无疾病生存率 (DFS).

关键词:
在早期阶段的NSCLC.免疫疗法 免疫疗法网络元分析 网络元分析个性化医疗是个性化的医疗.刻板印象性的身体辐射疗法.有针对性的治疗.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.7K

相关实验视频

Last Updated: Sep 20, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

201
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.7K

科学领域:

  • 在瘤学瘤学.
  • 医学研究 医学研究
  • 证据综合 证据综合

背景情况:

  • 对于早期非小细胞肺癌 (eNSCLC-N0) 的手术和非手术治疗方法进行比较,存在不确定性.
  • 优化治疗策略需要评估系统性疗法以及局部干预措施.

研究的目的:

  • 为了比较eNSCLC-N0.0.的各种治疗策略的疗效.
  • 基于综合证据综合的优越治疗方法的识别.

主要方法:

  • 进行了随机对照试验 (RCT) 和非RCT的综合证据综合.
  • 利用贝叶斯的随机效应网络元分析来评估治疗效应.
  • 主要结局包括整体存活率和无病存活率 (DFS).

主要成果:

  • 与混合激素切除相比,辅助向治疗 (ATKI) 显著改善了DFS.
  • 对于野生型/未知EGFR状态,SBRT加免疫检查点抑制剂显示DFS比单独SBRT更有好处.
  • SBRT加免疫疗法对DFS的辅助基化疗没有劣势.

结论:

  • 综合系统疗法,包括手术加ATKI或SBRT加免疫疗法,对于eNSCLC-N0.0来说更优越.
  • 治疗选择应考虑基因组突变状态和患者耐受性.
  • 这些发现指导了早期肺癌的个性化治疗策略.